コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d insulin secretion, adiposity, feeding, and glucose metabolism.
2 mpetitive endogenous RNAs in cholesterol and glucose metabolism.
3 idic because of low convective flow and high glucose metabolism.
4 health such as regulation of adipose tissue glucose metabolism.
5 describes how they impact islet biology and glucose metabolism.
6 ced metabolite from histidine, which impairs glucose metabolism.
7 ffecting the expression of genes involved in glucose metabolism.
8 und pregnancy-related physiologic changes in glucose metabolism.
9 ntricle at 8 d after TAC, indicating altered glucose metabolism.
10 ulators of inflammation as well as lipid and glucose metabolism.
11 inuum of metabolic disturbances in lipid and glucose metabolism.
12 tion of additional BCAAs will further impair glucose metabolism.
13 and tumor progression by reprogramming tumor glucose metabolism.
14 dependent on pathways inextricably linked to glucose metabolism.
15 ocesses, including the daily rhythm in human glucose metabolism.
16 ta3 antagonists for 1 month normalizes their glucose metabolism.
17 emed to play a role in regulating NKT cells' glucose metabolism.
18 ranscription factor in hepatic regulation of glucose metabolism.
19 A relevant role has been assigned to glucose metabolism.
20 ssive effects on both cell proliferation and glucose metabolism.
21 inating histone production, acetylation, and glucose metabolism.
22 tigate its effects on glucagon secretion and glucose metabolism.
23 increased weight gain with little effect on glucose metabolism.
24 nction, or expression of genes important for glucose metabolism.
25 eta-cell development, insulin secretion, and glucose metabolism.
26 tabolites as novel modulators of muscle cell glucose metabolism.
27 n increased FVIII synthesis or inhibition of glucose metabolism.
28 duct of this process, we examined changes in glucose metabolism.
29 ated the role of MALAT1 in regulating cancer glucose metabolism.
30 he renin-angiotensin system, and insulin and glucose metabolism.
31 play a role in regulating energy balance and glucose metabolism.
32 etite and decreases fat mass while improving glucose metabolism.
33 nism that partially underlies PF's effect on glucose metabolism.
34 y, shows that silencing SMS strongly impacts glucose metabolism.
35 ion, senescence, mitochondrial function, and glucose metabolism.
36 ic zebrafish further displayed dysfunctional glucose metabolism.
37 ly characterized for their role in lipid and glucose metabolism.
38 1 mediates the effects of insulin on hepatic glucose metabolism.
39 t in the intestine and to partially modulate glucose metabolism.
40 on is an important step in the regulation of glucose metabolism.
41 ort the concept of anticipatory budgeting on glucose metabolism.
42 FXR also regulates postprandial lipid and glucose metabolism.
43 acterized by insulin resistance and impaired glucose metabolism.
44 re of ATP-sensitive potassium channels after glucose metabolism.
45 adiposity, have been related to obesity and glucose metabolism.
46 king glycocalyx biology directly to cellular glucose metabolism.
47 genes associated with tumor development and glucose metabolism.
48 titians did not improve surrogate markers of glucose metabolism.
49 n the ileum and colon, modulated feeding and glucose metabolism.
50 glucose uptake and correspondingly increased glucose metabolism.
51 to nitric oxide (NO) signaling and impaired glucose metabolism.
52 inflammation, as well as improved lipid and glucose metabolism.
53 number of genes, including those involved in glucose metabolism.
54 roles in insulin secretion and consequently glucose metabolism.
55 ed protein which has recently been linked to glucose metabolism.
56 id, which is enabled by the reprogramming of glucose metabolism.
57 open up new ways to control food intake and glucose metabolism.
58 e decreased insulin signaling and disordered glucose metabolism.
59 ng tumorigenicity, sorafenib resistance, and glucose metabolism.
60 s beyond hepatic actions to exert control on glucose metabolism.
61 de evidence regarding a close interplay with glucose metabolism.
62 d, thus, obesity-associated deterioration of glucose metabolism.
63 ein through raised cellular intermediates of glucose metabolism.
64 insulin sensitivity, and measures of fasting glucose metabolism.
65 ing of the liver, including dysregulation of glucose metabolism.
66 from diet-induced obesity and its effects on glucose metabolism.
67 ated gene is implicated in the regulation of glucose metabolism.
68 FD-fed IgA-deficient mice have dysfunctional glucose metabolism, a phenotype that can be recapitulate
69 is increasing evidence that patients display glucose metabolism abnormalities before significant anti
71 at there is an exact proportionality between glucose metabolism and 2-FDG metabolism, called the lump
72 at there is an exact proportionality between glucose metabolism and 2-FDG metabolism, called the lump
73 anti-inflammatory activities, regulation of glucose metabolism and ability to stimulate fibroblast m
76 allows for an identification of patterns of glucose metabolism and amyloid deposition related to the
78 restriction leads to a marked improvement in glucose metabolism and body-fat composition, including l
80 m complications, including obesity, impaired glucose metabolism and cardiovascular disease, in both t
82 T is distinct from WAT and BAT, with altered glucose metabolism and decreased insulin responsiveness.
83 ells (K(ATP)-GOF) also lose the link between glucose metabolism and excitation-induced insulin secret
86 ects of MCH on food intake, body weight, and glucose metabolism and highlight the relevance of SIRT1/
89 e SAT weight and further improved CL-induced glucose metabolism and insulin sensitivity in female obe
90 ApoJ) as a novel hepatokine targeting muscle glucose metabolism and insulin sensitivity through a low
91 hysiological links between circadian clocks, glucose metabolism and insulin sensitivity, and present
94 ct of chitinase-3-like protein 1 (CHI3L1) on glucose metabolism and its underlying mechanisms in skel
95 cess functionally distinct from conventional glucose metabolism and leads to distinct metabolic requi
96 ein instability was associated with impaired glucose metabolism and lower glycolytic enzyme expressio
97 ul strategy in the prevention of the altered glucose metabolism and memory decline in these disorders
102 sterone ((18)F-FFNP) PET/CT imaging of tumor glucose metabolism and progesterone receptor (PR) expres
103 C1 expression may contribute to dysregulated glucose metabolism and represents a novel biomarker and
105 lude that PFKFB3 has a key role in mediating glucose metabolism and survival of NSCLC cells in respon
106 ning the effect of nitrate on adipose tissue glucose metabolism and the contribution of this tissue t
107 d, however, alter metabolic intermediates of glucose metabolism and those necessary for biosynthesis
109 vere human disorders resulting from abnormal glucose metabolism, and all previously described GSDs se
110 lucose-stimulated insulin secretion, hepatic glucose metabolism, and both adipose and pancreatic beta
111 ry nerves impacts pancreatic islet function, glucose metabolism, and diabetes onset, but how islet en
113 oss-sectional measures of amyloid-beta, tau, glucose metabolism, and grey matter degeneration in 15 c
114 records; measures of body fat, blood lipids, glucose metabolism, and inflammation were collected prio
116 e for NURR1 in governance of skeletal muscle glucose metabolism, and reveal a transcriptional link be
118 sulin and glucagon exert opposing actions on glucose metabolism, and their secretion is classically v
119 ven the widespread use of 2-FDG PET to infer glucose metabolism, appreciating the potential limitatio
120 al, suggesting that the effects of MALAT1 on glucose metabolism are essential for its oncogenic activ
124 es.Several metabolic factors affect cellular glucose metabolism as well as the innate inflammatory re
125 but less so with amyloid-beta deposition or glucose metabolism (assessed by positron emission tomogr
126 uitry (measured with PET imaging of cerebral glucose metabolism at baseline and at 6 and 12 months af
127 letal muscle lipid metabolism converges with glucose metabolism at the level of downstream RabGTPases
128 Expression levels of fatty acid oxidation, glucose metabolism, atrophy genes, and proteins as well
129 de novo cholesterol synthesis, fructose and glucose metabolism, basic amino acid metabolism, and bil
130 PC function, but not both, improves systemic glucose metabolism because of maintenance of AT regulato
131 eveals the mechanism by which YAP reprograms glucose metabolism, but also highlights the therapeutic
134 ation (tRES-HESP) corrected increased MG and glucose metabolism by increasing expression of Glo1 and
135 d that differential regulation of macrophage glucose metabolism by macrophage colony-stimulating fact
137 ated macrophages to D-mannose, which impairs glucose metabolism by raising intracellular mannose-6-ph
138 ally, CTRP6 regulates local inflammation and glucose metabolism by targeting macrophages and adipocyt
139 a mechanism by which alterations in cellular glucose metabolism can influence cellular inflammatory r
143 ver, the obese KO mice demonstrated improved glucose metabolism compared with wild-type mice. Obese K
144 o how TIH, prevalent in people with impaired glucose metabolism, contributes to cardiovascular diseas
145 sting-like gene expression profile, improves glucose metabolism, de-represses lncRNAs and impairs mam
146 secretion from islet beta-cells is driven by glucose metabolism, depolarization of the cell membrane
147 neurodegenerative disorders of ageing, brain glucose metabolism deteriorates in a progressive, region
148 volved in various cellular processes such as glucose metabolism, development, stress resistance, and
149 ting evidence suggests that individuals with glucose metabolism disorders are susceptible to mortalit
151 gene-sets not only predicted reduced risk of glucose metabolism disorders but was also consistent wit
154 eptor in skeletal-muscle AMPK activation and glucose metabolism during exercise, as well as unexpecte
158 utes to HCC development by regulating cancer glucose metabolism, enhancing glycolysis, and inhibiting
159 tion, apoptosis, inflammation, angiogenesis, glucose metabolism, erythropoiesis, and other physiologi
160 wever, we also reported that PF can increase glucose metabolism even in the absence of insulin in mus
161 se model whether early or late components of glucose metabolism, exemplified by fluorine 18 ((18)F) f
162 ly regulated a total of 237 DEGs involved in glucose metabolism, fatty acid oxidation, ion channels,
163 ired 30-50% of the cells to have near-normal glucose metabolism, fewer than cells with normal K(ATP)
167 a differentiation trajectory that regulates glucose metabolism genes to determine the proliferative
168 In addition to its role in the regulation of glucose metabolism, glucagon has been described to promo
169 1 diabetes that are associated with altered glucose metabolism/glycolysis and report here that TG2 e
170 of RS was evaluated by monitoring body fat, glucose metabolism, gut hormones, gut microbiota, short-
172 xamining the effect of coffee consumption on glucose metabolism have been limited by the use of surro
175 e therefore has a wide-ranging alteration in glucose metabolism: high [Ca(2+)](cytosol) activates PhK
176 glucose, demonstrating that acutely reduced glucose metabolism impairs cognition selectively in the
177 dehydrogenase (G6PD), an enzyme involved in glucose metabolism, improved survival in mouse models of
178 ocumented that 5-PAHSA primes adipocytes for glucose metabolism in a different way from insulin, prom
179 aster regulator of bioenergetics crucial for glucose metabolism in acute myeloid leukemia (AML), and
182 arbon flux through pathways of oxidation and glucose metabolism in bovine hepatocytes exposed to incr
184 phosphate receptor-1 (S1PR1) expression and glucose metabolism in CD4(+) T cells as potential mechan
185 ing feeding circuits, energy expenditure and glucose metabolism in concert are currently being explor
187 ntify a MAFG-lncRNA axis controlling hepatic glucose metabolism in health and metabolic disease.
191 We detected significant changes in cerebral glucose metabolism in key anorexia nervosa-related struc
192 e also show that STRIDE can be used to image glucose metabolism in many mouse tissues, including tumo
193 ons in overall body fat content and improved glucose metabolism in mice fed either regular chow or a
194 ect on metabolic flexibility or postprandial glucose metabolism in middle-aged overweight subjects.
195 e potential mechanisms by which PF increases glucose metabolism in muscle and liver cells independent
196 objectives were to measure insulin-sensitive glucose metabolism in neonatal lambs with IUGR and to de
197 ies have reported that EGFR signaling drives glucose metabolism in NSCLC cells; however, the precise
198 rmine the effects of BCAA supplementation on glucose metabolism in obese, prediabetic individuals.
201 s study revealed different patterns of brain glucose metabolism in patients with severe and mild phen
202 s study revealed different patterns of brain glucose metabolism in patients with the severe and mild
204 males, spontaneous opioid withdrawal altered glucose metabolism in regions associated with reward and
205 BDNF may be a key factor mediating increased glucose metabolism in response to exercise, with implica
208 d key biomarkers of inflammation, lipid, and glucose metabolism in the blood of patients with moderat
209 cadian clock, GSIS, islet transcriptome, and glucose metabolism in the context of diet-induced obesit
211 s ever investigated the alterations of brain glucose metabolism in these subjects by means of [(18)F]
213 a major role in the dysregulation of hepatic glucose metabolism in type-2 diabetes(1-3), the mechanis
216 These data reveal that increased platelet glucose metabolism in vivo contributes to increased plat
217 irect genetic evidence for the importance of glucose metabolism in Wnt-induced bone formation is lack
219 s and beta-cell function, indices of healthy glucose metabolism, in obese mice and obese, prediabetic
220 inopathy we found significant alterations in glucose metabolism including increased pyruvate, suggest
221 o assess whether CHADN could improve hepatic glucose metabolism independent of a change in insulin re
224 nalysis of 27 plasma biomarkers representing glucose metabolism, inflammation, adipokines, endothelia
225 ts of high compared with low dairy intake on glucose metabolism, insulin sensitivity, and metabolic f
226 eritoneal glucose tolerance test (IPGTT) for glucose metabolism, insulin tolerance test (ITT), and hi
227 ention was not associated with any change in glucose metabolism: insulin secretion (mean difference,
228 ention was not associated with any change in glucose metabolism; insulin secretion (mean difference -
231 which begs the question of whether targeting glucose metabolism is a viable approach to control MPhi
233 in AD and amnestic mild cognitive impairment glucose metabolism is dramatically decreased, probably o
234 ical role remains controversial, and whether glucose metabolism is functionally different during full
235 estigated whether hypothalamic reactivity to glucose metabolism is impaired in AN.METHODSTwenty-four
237 ven the widespread use of 2-FDG PET to infer glucose metabolism, it is relevant to appreciate the pot
238 lycemic dividing RMCs initiates intermediate glucose metabolism, leading to increased cytosolic UDP s
239 cance of estrogen hormones for regulation of glucose metabolism, little is known about the roles of e
242 -strain loop area and compared with regional glucose metabolism measured by (18)F-fluorodeoxyglucose
243 sed flux of MG formation linked to increased glucose metabolism mediated by proteolytic stabilisation
245 studies in cells confirmed abnormalities in glucose metabolism, mitochondrial oxygen consumption, an
250 Our purpose was to use PET to evaluate the glucose metabolism of the inferior colliculus (IC) and p
252 tructure and function, body composition, and glucose metabolism on adult female and male Sprague Dawl
253 the findings suggest that familial abnormal glucose metabolism or a primary insulin signaling pathwa
255 should allow assessment of diseases in which glucose metabolism or storage is altered, for instance,
259 glucose homeostasis; however, remodeling of glucose metabolism pathways pales compared with adaptati
260 benefit of lifestyle intervention to improve glucose metabolism post transplantation is unproven.
261 benefit of lifestyle intervention to improve glucose metabolism posttransplantation is unproven.
262 inal pyruvate levels coupled to dysregulated glucose metabolism prior to detectable optic nerve degen
263 deoxyglucose ((18)F-FDG) PET, which assesses glucose metabolism, provide valuable and complementary i
264 ism by which the gut microbiota can modulate glucose metabolism, providing a potential approach for t
265 pathophysiology (VBP) studies of blood flow, glucose metabolism, regional homogeneity, and amplitude
270 oles for two dehydrogenase proteins in human glucose metabolism that may contribute to individual res
277 ecular pathways that respond to the state of glucose metabolism to drive the morula to blastocyst tra
278 dob) leads to a paradoxical up-regulation of glucose metabolism to favor hepatocellular carcinogenesi
279 myloids can be dissolved upon restoration of glucose metabolism to produce functional secreted FVIII.
280 allows a large minority of cells with normal glucose metabolism to promote glucose-stimulated [Ca(2+)
281 in-GHSR axis modulates insulin secretion and glucose metabolism using mouse models lacking ghrelin (G
283 n seven thalamic nuclei using fMRI and brain glucose metabolism using positron emission tomography (P
285 stprandial interorgan crosstalk of lipid and glucose metabolism was evaluated, by determining postpra
286 lation of cells deficient in GK activity and glucose metabolism was imposed on the islet or in which
287 n of genes involved in insulin signaling and glucose metabolism was performed using specific arrays.
288 B1alpha and SH2B1delta in energy balance and glucose metabolism, we generated mice lacking these brai
289 e of these differentially abundant miRNAs on glucose metabolism, we transfected miR-20b-5p, a highly
292 Mitochondrial function and fatty acid and glucose metabolism were impaired in HF-patients compared
296 T2 isoform is critical for insulin-regulated glucose metabolism, while the role of the AKT1 isoform r
298 r tracer for Abeta and [(18)F]FDG tracer for glucose metabolism) with a novel analytical framework, w
299 (IGFs), specifically IGF1 and IGF2, promote glucose metabolism, with their availability regulated by
300 ring, there was a reduced change in cerebral glucose metabolism within the cognitive corticothalamic